InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Innate Pharma SA

IPHA Clue Score11
France Fiscal year ends December CIK 0001598599
$1.62 +9.46% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.62 −72.82% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Oct 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue44.0Operating income−40.0Net income−48.4EPS, diluted−0.89Fiscal year 2018Revenue94.0 +113.4%Operating income5.1Net income3.0EPS, diluted0.05Fiscal year 2019Revenue85.4 −9.1%Operating income1.6Net income−20.8 −780.8%EPS, diluted−0.31 −720.0%Fiscal year 2020Revenue69.8 −18.3%Operating income1.1Net income−64.0EPS, diluted−0.81Fiscal year 2021Revenue24.7 −64.6%Operating income−47.8Net income−52.8EPS, diluted−0.66Fiscal year 2022Revenue57.7 +133.5%Operating income−57.4Net income−58.1EPS, diluted−0.73Fiscal year 2023Revenue61.6 +6.9%Operating income−12.7Net income−7.6EPS, diluted−0.09Fiscal year 2024Revenue20.1 −67.4%Operating income−51.6Net income−49.5EPS, diluted−0.61Fiscal year 2025Revenue9.0 −55.2%Operating income−54.0Net income−49.2EPS, diluted−0.55
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 44.0 94.0 85.4 69.8 24.7 57.7 61.6 20.1 9.0
Growth +113.4% −9.1% −18.3% −64.6% +133.5% +6.9% −67.4% −55.2%
Operating income −40.0 5.1 1.6 1.1 −47.8 −57.4 −12.7 −51.6 −54.0
Net income −48.4 3.0 −20.8 −64.0 −52.8 −58.1 −7.6 −49.5 −49.2
Growth −780.8%
EPS, diluted −0.89 0.05 −0.31 −0.81 −0.66 −0.73 −0.09 −0.61 −0.55
Growth −720.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−90.8%Net margin−109.9%Free cash flow margin−115.9%Fiscal year 2018Operating margin5.5%Net margin3.2%Free cash flow margin−35.6%Fiscal year 2019Operating margin1.8%Net margin−24.3%Free cash flow margin39.4%Fiscal year 2020Operating margin1.5%Net margin−91.7%Free cash flow margin−75.5%Fiscal year 2021Operating margin−193.6%Net margin−213.8%Free cash flow margin−240.4%Fiscal year 2022Operating margin−99.6%Net margin−100.7%Free cash flow margin−34.1%Fiscal year 2023Operating margin−20.6%Net margin−12.3%Free cash flow margin−53.4%Fiscal year 2024Operating margin−256.3%Net margin−245.9%Free cash flow margin−36.2%Fiscal year 2025Operating margin−599.8%Net margin−546.1%Free cash flow margin−587.4%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −90.8% 5.5% 1.8% 1.5% −193.6% −99.6% −20.6% −256.3% −599.8%
Net margin −109.9% 3.2% −24.3% −91.7% −213.8% −100.7% −12.3% −245.9% −546.1%
Free cash flow margin −115.9% −35.6% 39.4% −75.5% −240.4% −34.1% −53.4% −36.2% −587.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−48.1Capital expenditure−3.0Free cash flow−51.0Fiscal year 2018Operating cash flow−32.5Capital expenditure−0.9Free cash flow−33.4Fiscal year 2019Operating cash flow34.9Capital expenditure−1.3Free cash flow33.7Fiscal year 2020Operating cash flow−51.8Capital expenditure−0.9Free cash flow−52.7 −256.5%Fiscal year 2021Operating cash flow−58.5Capital expenditure−0.9Free cash flow−59.4Fiscal year 2022Operating cash flow−19.2Capital expenditure−0.5Free cash flow−19.7Fiscal year 2023Operating cash flow−32.6Capital expenditure−0.4Free cash flow−32.9Fiscal year 2024Operating cash flow−6.9Capital expenditure−0.4Free cash flow−7.3Fiscal year 2025Operating cash flow−52.8Capital expenditure−0.1Free cash flow−52.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −48.1 −32.5 34.9 −51.8 −58.5 −19.2 −32.6 −6.9 −52.8
Capital expenditure −3.0 −0.9 −1.3 −0.9 −0.9 −0.5 −0.4 −0.4 −0.1
Free cash flow −51.0 −33.4 33.7 −52.7 −59.4 −19.7 −32.9 −7.3 −52.9
Growth −256.5%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash99.4Shareholders’ equity99.4Fiscal year 2018Cash152.3Shareholders’ equity167.1Fiscal year 2019Cash202.9Shareholders’ equity217.4Fiscal year 2020Cash136.8Shareholders’ equity156.0Fiscal year 2021Cash103.8Shareholders’ equity107.4Fiscal year 2022Cash84.2Shareholders’ equity54.2Fiscal year 2023Cash70.6Shareholders’ equity51.9Fiscal year 2024Cash66.4Shareholders’ equity8.8Fiscal year 2025Cash28.1Shareholders’ equity−21.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 99.4 152.3 202.9 136.8 103.8 84.2 70.6 66.4 28.1
Shareholders’ equity 99.4 167.1 217.4 156.0 107.4 54.2 51.9 8.8 −21.7

In millions of EUR, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−90.8% 5.5% 1.8% 1.5% −193.6% −99.6% −20.6% −256.3% −599.8%
−109.0% 2.9% 9.2% −1.2% −184.1% −100.5% −12.3% −245.9% −546.1%
−109.9% 3.2% −24.3% −91.7% −213.8% −100.7% −12.3% −245.9% −546.1%
−115.9% −35.6% 39.4% −75.5% −240.4% −34.1% −53.4% −36.2% −587.4%
Spending
152.2% 74.0% 73.6% 71.2% 190.3% 89.6% 90.9% 258.3% 484.4%
38.6% 19.3% 24.5% 27.2% 103.3% 38.9% 29.7% 98.0% 215.4%
6.7% 0.9% 1.5% 1.3% 3.8% 0.9% 0.6% 1.9% 1.6%
n/a −12.3% 0.0% n/a n/a n/a n/a n/a n/a
Returns
−48.7% 1.8% −9.5% −41.0% −49.2% −107.3% −14.6% −560.0% n/a
−19.0% 0.7% −5.2% −20.8% −19.7% −29.2% −4.3% −44.5% −78.4%

Shown in EUR as filed; the screener converts to dollars.